These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


273 related items for PubMed ID: 6182460

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. [Oral longterm therapy with disopyramide phosphate in patients with atrial and ventricular arrhythmias (author's transl)].
    Stauch M, Grewe N.
    MMW Munch Med Wochenschr; 1977 Dec 02; 119(48):1563-6. PubMed ID: 74799
    [Abstract] [Full Text] [Related]

  • 44. [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)].
    Klempt HW, Nayebagha A, Fabry E.
    Z Kardiol; 1982 May 02; 71(5):340-9. PubMed ID: 6180562
    [Abstract] [Full Text] [Related]

  • 45. [Comparative study of quinidine and disopyramide in the treatment of stable ventricular extrasystole].
    Barnay C, Medvedowsky JL, Clémenty J, Bricaud H, Pellet J, Denis B, Machecourt J, Wolf JE, Dimitrio R, Egre A.
    Arch Mal Coeur Vaiss; 1983 Aug 02; 76(8):909-17. PubMed ID: 6194768
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [Antiarrhythmic effect of disopyramid retard versus propranolol retard in ventricular extrasystole].
    Fechter P, Nager F.
    Schweiz Med Wochenschr; 1982 Dec 18; 112(51):1897-900. PubMed ID: 6187065
    [Abstract] [Full Text] [Related]

  • 48. Comparison of propafenone and disopyramide for treatment of chronic ventricular arrhythmias: placebo-controlled, double-blind, randomized crossover study.
    Naccarella F, Bracchetti D, Palmieri M, Cantelli I, Bertaccini P, Ambrosioni E.
    Am Heart J; 1985 Apr 18; 109(4):833-40. PubMed ID: 3885700
    [Abstract] [Full Text] [Related]

  • 49. [Comparative effectiveness of class I anti-arrhythmia drugs and the algorithms of their selection in patients with ventricular arrhythmia].
    Abdalla A, Mazur NA, Nazarenko VA.
    Kardiologiia; 1991 Jun 18; 31(6):22-5. PubMed ID: 1717733
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [Multicenter comparative studies of the effectiveness and tolerance of propafenone and disopyramide in the treatment of premature ventricular beats].
    Lukasik S, Nowosad H, Grzelak H, Kowalewski W, Kowalisko A.
    Pol Arch Med Wewn; 1987 Jun 18; 77(6):291-9. PubMed ID: 2482478
    [No Abstract] [Full Text] [Related]

  • 54. [Comparative effectiveness of neogilurytmal, novocainamide, etmozin, disopyramide and ethacizine in ventricular arrhythmias].
    Shpektor AV, Gorshkov VA, Mamaev VI.
    Klin Med (Mosk); 1987 Jan 18; 65(1):49-52. PubMed ID: 2435956
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. [Comparative studies of tocainide and propafenone in the treatment of ventricular arrhythmias].
    Gebhardt A, Schmuderer R, Hilpert P.
    Arzneimittelforschung; 1984 Jan 18; 34(3):303-6. PubMed ID: 6428425
    [Abstract] [Full Text] [Related]

  • 58. [Holter analysis of ventricular arrhythmias and its treatment with propafenone].
    Peralta Heredia R.
    Arch Inst Cardiol Mex; 1986 Jan 18; 56(3):225-30. PubMed ID: 2428317
    [Abstract] [Full Text] [Related]

  • 59. [Therapy of ventricular tachyarrhythmia with disopyramid phosphate].
    Steinbrunn W, Mattmann H, Enrico JF, Engel U.
    Schweiz Med Wochenschr; 1980 Jun 14; 110(24):953-7. PubMed ID: 7414314
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.